Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Sailike Pharmaceutical is a comprehensive pharmaceutical enterprise located in the Haikou National High-tech Industrial Development Zone, China. Founded in 2003, the company integrates drug research, development, production, and marketing, with a primary focus on chemical formulations. Its product portfolio spans several critical therapeutic areas, including anti-infectives, cardiovascular diseases, endocrine disorders, and digestive system health. Sailike operates advanced production lines for tablets, capsules, and granules, all of which maintain national GMP certification. The company is particularly recognized for its core products like Saifuxi (Cefixime) and Sailike (Azithromycin), which have established a significant market presence in China. As a designated high-tech enterprise, it continues to invest in quality improvement and the development of high-quality generic medications to serve the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 海南赛立克药业.